切換：
- 簡略
- 詳細(MARC)
- ISBD
-
Drug development in psychiatry /
紀錄類型 ： 書目-語言資料,印刷品: 單行本
其他作者 ： Macaluso, Matthew,
出版項 ： Cham, Switzerland :Springer,[2023]
面頁冊數 ： 1 online resource (519 pages) :illustrations (black and white, and colour).
內容註 ： Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development -- The History of Drug Development in Psychiatry: A Lesson in Serendipity -- The Evolving Role of Animal Models in the Discovery and Development of Novel Treatments for Psychiatric Disorders -- Discovery and Development of Monoamine Transporter Ligands -- Drug Development for New Psychiatric Drug Therapies -- Post-Approval Research in Drug Development: Priorities and Practices -- Discovery of new transmitter systems and hence new drug targets -- Reverse engineering drugs -- Back to the Future of Neuropsychopharmacology -- Targeted Treatments for Fragile X Syndrome -- The Difficult Path to the Discovery of Novel Treatments in Psychiatric Disorders Diseases -- Biomarkers in Psychiatric Drug Development: From Precision Medicine to Novel Therapeutics -- The role of fMRI in drug development: an update -- Monoamine Oxidase B (MAO-B): A Target for Rational Drug Development in Schizophrenia Using PET Imaging as an Example -- Genomics in Treatment Development -- Increased Inflammation and Treatment of Depression: from Resistance to Reuse, Repurposing and Redesign -- Experimental medicine approaches in early phase CNS drug development.
標題 ： Psychotropic drugs - Development. -
標題 ： Drug development. -
ISBN ： 9783031210549
ISBN ： 3031210549
LEADER 02817nam 22003857i 4500
001 51458
003 NhCcYBP
005 20230824202140.0
006 m o d
007 cr cnu---unuuu
008 230327s2023 sz a o 001 0 eng d
020 $a9783031210549$qelectronic book
020 $a3031210549$qelectronic book
020 $z3031210530
020 $z9783031210532
024 7 $a10.1007/978-3-031-21054-9$2doi
035 $aebs3576943
040 $aNhCcYBP$cNhCcYBP
041 $aeng
050 4$aRM315$b.D78 2023
072 7$aPSAN$2bicssc
072 7$aMED057000$2bisacsh
072 7$aPSAN$2thema
082 04$a615.7/88$223/eng/20230327
245 00$aDrug development in psychiatry /$cMatthew Macaluso, Sheldon H. Preskorn, Richard C. Shelton, editors.
264 1$aCham, Switzerland :$bSpringer,$c[2023]
300 $a1 online resource (519 pages) :$billustrations (black and white, and colour).
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
490 1 $aAdvances in neurobiology ;$v30
505 0 $aDrug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development -- The History of Drug Development in Psychiatry: A Lesson in Serendipity -- The Evolving Role of Animal Models in the Discovery and Development of Novel Treatments for Psychiatric Disorders -- Discovery and Development of Monoamine Transporter Ligands -- Drug Development for New Psychiatric Drug Therapies -- Post-Approval Research in Drug Development: Priorities and Practices -- Discovery of new transmitter systems and hence new drug targets -- Reverse engineering drugs -- Back to the Future of Neuropsychopharmacology -- Targeted Treatments for Fragile X Syndrome -- The Difficult Path to the Discovery of Novel Treatments in Psychiatric Disorders Diseases -- Biomarkers in Psychiatric Drug Development: From Precision Medicine to Novel Therapeutics -- The role of fMRI in drug development: an update -- Monoamine Oxidase B (MAO-B): A Target for Rational Drug Development in Schizophrenia Using PET Imaging as an Example -- Genomics in Treatment Development -- Increased Inflammation and Treatment of Depression: from Resistance to Reuse, Repurposing and Redesign -- Experimental medicine approaches in early phase CNS drug development.
533 $aElectronic reproduction.$bIpswich, MA$nAvailable via World Wide Web.
588 $aDescription based on online resource; title from digital title page (viewed on April 27, 2023).
650 0$aPsychotropic drugs$xDevelopment.$398856
650 0$aDrug development.$380152
700 1 $aMacaluso, Matthew,$eeditor.$392461
700 1 $aPreskorn, Sheldon,$eeditor.$398857
700 1 $aShelton, Richard C.,$eeditor.$398858
710 2 $aEBSCOhost$387894
776 08$iPrint version:$tDRUG DEVELOPMENT IN PSYCHIATRY.$d[Place of publication not identified] : SPRINGER INTERNATIONAL PU, 2023$z3031210530
830 0$aAdvances in neurobiology ;$v29.$392387
856 40$uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3576943$zClick to View (限總院院內)
Drug development in psychiatry /Matthew Macaluso, Sheldon H. Preskorn, Richard C. Shelton, editors. - 1 online resource (519 pages) :illustrations (black and white, and colour). - Advances in neurobiology ;30. - Advances in neurobiology ;29..
Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development -- The History of Drug Development in Psychiatry: A Lesson in Serendipity -- The Evolving Role of Animal Models in the Discovery and Development of Novel Treatments for Psychiatric Disorders -- Discovery and Development of Monoamine Transporter Ligands -- Drug Development for New Psychiatric Drug Therapies -- Post-Approval Research in Drug Development: Priorities and Practices -- Discovery of new transmitter systems and hence new drug targets -- Reverse engineering drugs -- Back to the Future of Neuropsychopharmacology -- Targeted Treatments for Fragile X Syndrome -- The Difficult Path to the Discovery of Novel Treatments in Psychiatric Disorders Diseases -- Biomarkers in Psychiatric Drug Development: From Precision Medicine to Novel Therapeutics -- The role of fMRI in drug development: an update -- Monoamine Oxidase B (MAO-B): A Target for Rational Drug Development in Schizophrenia Using PET Imaging as an Example -- Genomics in Treatment Development -- Increased Inflammation and Treatment of Depression: from Resistance to Reuse, Repurposing and Redesign -- Experimental medicine approaches in early phase CNS drug development.
Electronic reproduction.
Ipswich, MA
Available via World Wide Web.
ISBN: 9783031210549
Standard No.: 10.1007/978-3-031-21054-9doiSubjects--Topical Terms:
98856
Psychotropic drugs
--Development.
LC Class. No.: RM315 / .D78 2023
Dewey Class. No.: 615.7/88
Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development -- The History of Drug Development in Psychiatry: A Lesson in Serendipity -- The Evolving Role of Animal Models in the Discovery and Development of Novel Treatments for Psychiatric Disorders -- Discovery and Development of Monoamine Transporter Ligands -- Drug Development for New Psychiatric Drug Therapies -- Post-Approval Research in Drug Development: Priorities and Practices -- Discovery of new transmitter systems and hence new drug targets -- Reverse engineering drugs -- Back to the Future of Neuropsychopharmacology -- Targeted Treatments for Fragile X Syndrome -- The Difficult Path to the Discovery of Novel Treatments in Psychiatric Disorders Diseases -- Biomarkers in Psychiatric Drug Development: From Precision Medicine to Novel Therapeutics -- The role of fMRI in drug development: an update -- Monoamine Oxidase B (MAO-B): A Target for Rational Drug Development in Schizophrenia Using PET Imaging as an Example -- Genomics in Treatment Development -- Increased Inflammation and Treatment of Depression: from Resistance to Reuse, Repurposing and Redesign -- Experimental medicine approaches in early phase CNS drug development.
Electronic reproduction.
Ipswich, MA
Available via World Wide Web.
ISBN: 9783031210549
Standard No.: 10.1007/978-3-031-21054-9doiSubjects--Topical Terms:
98856
Psychotropic drugs
--Development.
LC Class. No.: RM315 / .D78 2023
Dewey Class. No.: 615.7/88
- 館藏(0)
- 心得(0)
- 標籤
- 相同喜好的讀者(0)
- 相關資料(0)
發表心得